SHANGHAI, Jan 30 (Reuters) - Sciwind Biosciences' type 2 diabetes treatment Xianyida was approved for use in China, the company said on Friday, adding another participant to a hot sector in the ...
Ascletis Pharma has dosed the first participants in a US Phase II trial of ASC30, an oral small molecule glucagon-like ...
Recent advances in diabetes detection may help to identify risk earlier. In this article, MNT discusses recent studies that ...
The City of El Paso Department of Public Health (DPH) is offering free A1C testing to the community on “Take Charge Tuesdays” ...
Numerous genetic studies have identified many risk variants for type 2 diabetes (T2D)—but which genes and proteins are ...
Is your backside trying to tell you something? New research suggests that the shape of the GM — not just the size — could be ...
News Medical on MSN
Study uncovers genes and proteins likely to play a causal role in Type 2 diabetes
An international study co-led by researchers from the University of Massachusetts Amherst and Helmholtz Munich in Germany has ...
Around 12.1% of Black Americans have diabetes compared with about 6.9% of non-Hispanic White adults, according to the ...
News-Medical.Net on MSN
Nearly half of adults now live with heart disease as obesity and diabetes surge
By Tarun Sai Lomte From rising obesity and diabetes to stubborn health inequities, the AHA’s latest statistics reveal why ...
Researchers have identified a protein pattern that, already at birth, looks markedly different in those who later go on to ...
Deaths due to diabetes rise by nearly 35 per cent in Delhi in 2024: Report ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results